Prospettive di farmacologia molecolare in oncologia

Translated title of the contribution: Methods of molecular pharmacology in oncology

Research output: Contribution to journalArticle

Abstract

The evaluation of the precise mechanism of action of a new anticancer agent is a crucial step for a better utilization of drugs in cancer therapy. The increased knowledge of the molecular alterations present in different tumors, combined with the identification of the intracellular targets of a drug is the initial step for the possible, future molecular-oriented chemotherapy. It is in fact possible now to know if and how a given drug is able to interact with DNA and if the DNA sequence is a key factor in determining such interaction. Drugs are available with high sequence specificity of DNA interaction and these results, combined with the knowledge of the DNA sequences important for the regulation of gene expression, can help in identifying possible intracellular targets of the drugs. The recent introduction of the microarray technology has changed our approach to the study of drug effects on gene expression. In a single experiment is possible to identify changes in gene expression of plenty of genes and to have information on the alterations in the expression of gene families. These studies, combined to the effects on proteins involved in cell cycle control and in the induction of apoptosis, allow a better understanding of the interaction between drugs and cellular control mechanisms.

Original languageItalian
Pages (from-to)93-97
Number of pages5
JournalRecenti Progressi in Medicina
Volume92
Issue number2
Publication statusPublished - Feb 2001

Fingerprint

Pharmacology
Pharmaceutical Preparations
Gene Expression
Drug Utilization
Drug and Narcotic Control
Gene Expression Regulation
Cell Cycle Checkpoints
Antineoplastic Agents
Neoplasms
Apoptosis
Technology
Drug Therapy
DNA
Genes
Proteins
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prospettive di farmacologia molecolare in oncologia. / Broggini, Massimo.

In: Recenti Progressi in Medicina, Vol. 92, No. 2, 02.2001, p. 93-97.

Research output: Contribution to journalArticle

@article{c9299cad2177499785822ebce186002c,
title = "Prospettive di farmacologia molecolare in oncologia",
abstract = "The evaluation of the precise mechanism of action of a new anticancer agent is a crucial step for a better utilization of drugs in cancer therapy. The increased knowledge of the molecular alterations present in different tumors, combined with the identification of the intracellular targets of a drug is the initial step for the possible, future molecular-oriented chemotherapy. It is in fact possible now to know if and how a given drug is able to interact with DNA and if the DNA sequence is a key factor in determining such interaction. Drugs are available with high sequence specificity of DNA interaction and these results, combined with the knowledge of the DNA sequences important for the regulation of gene expression, can help in identifying possible intracellular targets of the drugs. The recent introduction of the microarray technology has changed our approach to the study of drug effects on gene expression. In a single experiment is possible to identify changes in gene expression of plenty of genes and to have information on the alterations in the expression of gene families. These studies, combined to the effects on proteins involved in cell cycle control and in the induction of apoptosis, allow a better understanding of the interaction between drugs and cellular control mechanisms.",
keywords = "Apoptosis, Cell cycle, DNA repair, Molecular-oriented chemotherapy, Transcription",
author = "Massimo Broggini",
year = "2001",
month = "2",
language = "Italian",
volume = "92",
pages = "93--97",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "2",

}

TY - JOUR

T1 - Prospettive di farmacologia molecolare in oncologia

AU - Broggini, Massimo

PY - 2001/2

Y1 - 2001/2

N2 - The evaluation of the precise mechanism of action of a new anticancer agent is a crucial step for a better utilization of drugs in cancer therapy. The increased knowledge of the molecular alterations present in different tumors, combined with the identification of the intracellular targets of a drug is the initial step for the possible, future molecular-oriented chemotherapy. It is in fact possible now to know if and how a given drug is able to interact with DNA and if the DNA sequence is a key factor in determining such interaction. Drugs are available with high sequence specificity of DNA interaction and these results, combined with the knowledge of the DNA sequences important for the regulation of gene expression, can help in identifying possible intracellular targets of the drugs. The recent introduction of the microarray technology has changed our approach to the study of drug effects on gene expression. In a single experiment is possible to identify changes in gene expression of plenty of genes and to have information on the alterations in the expression of gene families. These studies, combined to the effects on proteins involved in cell cycle control and in the induction of apoptosis, allow a better understanding of the interaction between drugs and cellular control mechanisms.

AB - The evaluation of the precise mechanism of action of a new anticancer agent is a crucial step for a better utilization of drugs in cancer therapy. The increased knowledge of the molecular alterations present in different tumors, combined with the identification of the intracellular targets of a drug is the initial step for the possible, future molecular-oriented chemotherapy. It is in fact possible now to know if and how a given drug is able to interact with DNA and if the DNA sequence is a key factor in determining such interaction. Drugs are available with high sequence specificity of DNA interaction and these results, combined with the knowledge of the DNA sequences important for the regulation of gene expression, can help in identifying possible intracellular targets of the drugs. The recent introduction of the microarray technology has changed our approach to the study of drug effects on gene expression. In a single experiment is possible to identify changes in gene expression of plenty of genes and to have information on the alterations in the expression of gene families. These studies, combined to the effects on proteins involved in cell cycle control and in the induction of apoptosis, allow a better understanding of the interaction between drugs and cellular control mechanisms.

KW - Apoptosis

KW - Cell cycle

KW - DNA repair

KW - Molecular-oriented chemotherapy

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=0035257449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035257449&partnerID=8YFLogxK

M3 - Articolo

C2 - 11294113

AN - SCOPUS:0035257449

VL - 92

SP - 93

EP - 97

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 2

ER -